Drug Index


Synonym :


Mechanism :

Bleomycin is an anti-neoplastic agent. The exact mechanism of action is unknown, available evidence indicates that the main mode of action is the inhibition of DNA synthesis with some evidence of lesser inhibition of RNA and protein synthesis.

Indication :

  • Hodgkin lymphoma
  • Malignant effusions
  • Glioma
  • Germ cell tumours

Contraindications :

Contraindicated in patients who have demonstrated a hypersensitivity or an idiosyncratic reaction to it and in reduced pulmonary function.

Dosing :

Not recommended in children. Always consult the recent protocol for detailed dosage and schedule.
Squamous cell carcinoma:
0.25 to 0.50 units/kg (10 to 20 units/m²) IV/IM/SC weekly or twice weekly.
Non-Hodgkin’s Lymphoma:
Test dose 1 to 2 units of bleomycin for the first two doses, it is necessary to wait for at least an hour before administering the remainder of the dose 0.25 to 0.50 units/kg (10 to 20 units/m²) IV/IM/SC weekly or twice weekly.
Germ cell tumors:
15 units/m²/dose once weekly IV/IM/SC for 3 weeks per regimen.
Hodgkin’s Lymphoma:
10 units/m²/dose on days 1 and 15 of the cycle. IV continuous infusion: 15-20 units/m²/day over 24 hours for 3-5 days.

Adverse Effect :

Pneumonitis occasionally progressing to pulmonary fibrosis, acute febrile reaction, idiosyncratic Reactions (hypotension, mental confusion, chills, and wheezing), erythema, rash, striae, vesiculation, hyperpigmentation, hyperkeratosis, alopecia, pruritus, stomatitis.

Interaction :

Concurrent use with phenytoin decreases the phenytoin levels, Cisplatin decreases the clearance of bleomycin, Bleomycin may decrease digoxin absorption, concurrent use with amphotericin B products may increase nephrotoxicity and risk for hypotension and bronchospasm.

Renal Dose :

Dose in Renal Impairment GFR (mL/min)
20-50Dose as in normal renal function
10-2075% of normal dose (100% for malignant effusions)
<1050% of normal dose (100% for malignant effusions)

Dose in Patients undergoing Renal Replacement Therapies
CAPDNot dialysed. Dose as in GFR<10 mL/min
HDNot dialysed. Dose as in GFR<10 mL/min
HDF/High fluxUnknown dialysability. Dose as in GFR<10 mL/min
CAV/VVHDUnknown dialysability. Dose as in GFR=10–20 mL/min

Hepatic Dose :

No dosage adjustments are recommended.
03/13/2024 05:27:37 Bleomycin
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0